ATLANTA — Georgia Governor Nathan Deal announced Thursday that Baxter International will locate a new bio-pharmaceutical manufacturing facility near Atlanta as well as plasma centers throughout Georgia that will employ approximately 1,500 people across the state with the potential for hundreds more.
Total investment by the company will exceed $1 billion.
“Baxter’s decision to come to Georgia marks a new era in the growth of our biosciences industry and will have far-reaching impact on our economy,” said Deal. “We are honored to welcome this flagship company to Georgia and proud that our state’s vast resources for the biomedical field will assist the company with the groundbreaking medical advances it is renowned for. Baxter’s commitment to Georgia moves us closer to making Georgia the No. 1 state in which to do business.”